Essential Pharma teams up with international health partners to launch campaign to donate life-saving medicines to disaster-hit countries
Donations will help support over 30,000 patients in vulnerable disaster-hit areas around the world and reduce medicine waste.
Antibiotics, cardiovascular and mental health medications are included in International Health Partners’ (IHP) signature programs to maximize impact for patients.
Egham, UK – 10 July 2024 – Essential Pharma, an international specialty pharmaceutical group focused on ensuring continued patient access to small-quantity, clinically differentiated niche medicines in key therapeutic areas, today launches a campaign to donate critical medicines to more than 30,000 patients in collaboration with International Health Partners (IHP), a global health NGO working to improve access to healthcare for people in vulnerable communities affected by disasters.
IHP leverages its quality control, warehousing and logistics expertise to improve access to healthcare around the world, facilitating and delivering donations of essential medicines to those who need them most. Essential Pharma’s medicine donations include antibiotics and medicines for cardiovascular and psychiatric diseases that strengthen vulnerable and disaster-hit healthcare systems and ensure those communities have access to a wide range of medicines free at the point of use. Donations of antibiotics and medicines for cardiovascular and psychiatric diseases in support of IHP’s signature programs in disaster response, mental health and non-communicable diseases are essential to meet these growing medical needs.
Lily Jones Herbst, Corporate Partnerships Manager, International Health Partners Commented“We are incredibly grateful for Essential Pharma’s generous donation of medicines, which will be life-saving for patients around the world who struggle to access the medicines they need. These donations are vital for our rapid disaster response, the sustainability of our long-term health programs, and the continued delivery of Essential Health Packs, which provide vital primary healthcare in any situation. On behalf of everyone at IHP, we thank Essential Pharma for this generous donation, which will play a key role in improving the health outcomes of thousands of patients around the world.”
“Today we are incredibly proud to announce our partnership with IHP, which will facilitate getting these life-saving medicines into the hands of patients who need them most. Every year, billions of pounds worth of usable medical supplies are wasted. By partnering with IHP we are not only supporting the global community but also reducing medicine waste and environmental impact in line with our ESG commitments.” Emma Johnson, CEO of Essential Pharma, said:“This partnership will allow EssentialPharma to leverage IHP’s connections in vulnerable and disaster-affected areas to address the persistent problem of access to medical supplies. We strive to help bridge the gap through our donation of these essential medicines and look forward to many more donations in the future.”
About Essential Pharma
Essential Pharma is an international specialty pharmaceutical group committed to maintaining access to clinically differentiated niche medicines in small patient populations. The group has been a key and valued partner to healthcare providers for over 20 years by providing underserved patient populations with access to medicines that may not otherwise be available, addressing clinical unmet needs. Essential Pharma operates in more than 70 countries worldwide and offers a product portfolio focused on the Central Nervous System (CNS), Gastroenterology, Ophthalmology and Rare Diseases. The group’s growth strategy is centered around portfolio optimization and a targeted M&A approach to acquire commercial and late-clinical stage assets in its four therapeutic focus areas. With a proven track record of integrating assets and seamlessly managing complex technology transfers whilst ensuring a continuous and sustainable supply to patients, the group is a trusted partner to pharmaceutical companies of all sizes.
Essential Pharma is backed by Gyrus Capital, an investment firm focused on making transformational investments in sectors with strong long-term sustainable growth, including healthcare.
For more information, please visit www.essentialpharmagroup.com.
About International Health Partners
International Health Partners (IHP) is a global health NGO working to improve access to healthcare for disaster-hit and vulnerable communities by coordinating the safe and responsible donation of high-quality medicines that can be used for a long time. Working with a strong global healthcare partner network, we source and send medicines to help people around the world. We respond quickly to humanitarian disasters, support long-term healthcare development projects, and provide supplies so doctors can do their jobs. IHP acts as a bridge between healthcare companies and humanitarian organizations, helping individuals and communities access the essential medicines and medical supplies they need. Its vision is to see a world where all suffering due to lack of healthcare is eradicated.
For more information, visit www.ihpuk.org
contact address
Essential Pharma
Emma Johnson CEO
Phone: +44(0)1784 477 167
Email: info@essentialpharmaceuticals.com
ICR Consilium
Tracy Chan/Chris Welsh/Isabelle Abdou
Phone: +44 (0) 20 3709 5700
Email: essentialpharma@icrhealthcare.com
International Health Partners (IHP)
Lily Jones Herbst, Corporate Partnerships Manager
Phone: +44 020 3735 5489
Email: info@ihpuk.org
